XML 36 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Data [Abstract]  
Quarterly Financial Data

16. Quarterly Financial Data (Unaudited)





The following tables summarize the unaudited quarterly statements of operations for the Company for the years ended December 31, 2016 and 2015. The tables include all necessary adjustments, consisting only of normal recurring adjustments necessary in the opinion of management for a fair statement of the results for interim periods.



As discussed in Note 3 of the Form 10-Q filed for the quarter ended September 30, 2016, the Company corrected an immaterial error in the condensed consolidated financial statements for the three months ended September 30, 2016.





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Quarter Ended (Unaudited)

2016

 

March 31,

 

June 30,

 

September 30,

 

December 31,

Revenue

$

106,000 

$

103,000 

$

29,000 

$

22,000 

Total operating expenses

 

4,624,000 

 

3,692,000 

 

3,436,000 

 

11,886,000 

Loss from operations

 

(4,518,000)

 

(3,589,000)

 

(3,407,000)

 

(11,864,000)

Other income (expense), net

 

1,406,000 

 

(262,000)

 

1,032,000 

 

1,808,000 

Net loss

 

(3,112,000)

 

(3,851,000)

 

(2,375,000)

 

(9,500,000)

Accretion of Series B redeemable convertible preferred stock

 

(1,725,000)

 

(133,000)

 

 -

 

 -

Excess of fair value of consideration transferred on conversion of Series B redeemable convertible preferred stock

 

 -

 

(2,366,000)

 

(1,214,000)

 

 -

Net loss attributable to common stockholders

 

(4,837,000)

 

(6,350,000)

 

(3,589,000)

 

(9,500,000)



 

 

 

 

 

 

 

 

Net loss per share of common stock

 

 

 

 

 

 

 

 

Basic

 

(0.82)

 

(0.73)

 

(0.32)

 

(0.70)

Diluted

 

(0.82)

 

(0.78)

 

(0.32)

 

(0.76)











 

 

 

 

 

 

 

 



 

Quarter Ended (Unaudited)

2015

 

March 31,

 

June 30,

 

September 30,

 

December 31,

Revenue

$

102,000 

$

102,000 

$

143,000 

$

128,000 

Total operating expenses

 

2,369,000 

 

2,694,000 

 

2,571,000 

 

3,068,000 

Loss from operations

 

(2,267,000)

 

(2,592,000)

 

(2,428,000)

 

(2,940,000)

Other income (expense), net

 

(12,226,000)

 

13,361,000 

 

7,867,000 

 

636,000 

Income tax benefit

 

 -

 

 -

 

 -

 

73,000 

Net (loss) income

 

(14,493,000)

 

10,769,000 

 

5,439,000 

 

(2,231,000)

Accretion of Series B redeemable convertible preferred stock

 

(338,000)

 

(1,828,000)

 

(7,163,000)

 

(949,000)

Net (loss) income attributable to common stockholders

 

(14,831,000)

 

8,941,000 

 

(1,724,000)

 

(3,180,000)



 

 

 

 

 

 

 

 

Net (loss) income per share of common stock

 

 

 

 

 

 

 

 

Basic

 

(3.49)

 

1.27 

 

(0.30)

 

(0.54)

Diluted

 

(3.49)

 

(0.33)

 

(0.30)

 

(0.54)